Receive our newsletter – data, insights and analysis delivered to you
  1. Deals
December 10, 2021updated 07 Jan 2022 8:29am

EBOS Group to acquire LifeHealthcare for $835m

With the acquisition of LifeHealthcare, EBOS will be able to accelerate its medical devices strategy.

EBOS Group has signed an agreement to acquire medical device distributor LifeHealthcare from Pacific Equity Partners-advised funds and other minority stakeholders for about $835m (A$1.167bn).

Under the terms of the deal, the company will acquire 100% of LifeHealthcare’s Australian and New Zealand subsidiaries along with 51% of Transmedic, its Asian subsidiary.

LifeHealthcare distributes third party medical devices, in-house manufactured allograft material, consumables and capital equipment in New Zealand, Australia and South East Asia.

Australia and New Zealand (ANZ) Distribution and Allografts, and Asia Distribution are the company’s two primary business divisions.

The acquisition of LifeHealthcare will allow EBOS to substantially accelerate its medical devices strategy and diversify its existing portfolio.

It will also allow EBOS to increase its exposure to the high growth medical devices sector and create a platform to capitalise on further growth opportunities in the future.

Content from our partners
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment

EBOS CEO John Cullity said: “The acquisition of LifeHealthcare represents an important step in EBOS’ medical devices strategy, providing greater exposure to this high growth sector as well as providing a measured entry into South East Asia.

“The acquisition aligns with our strategy to build a medical devices platform and provides an opportunity for future growth across existing and adjacent therapeutic areas.”

The company expects LifeHealthcare to generate between $78.7m (A$110m) and $81.57m (A$114m) EBITDA in the calendar year 2022.

The transaction, which is subject to multiple closing conditions and regulatory approvals, is anticipated to be concluded before the end of the fiscal year 2022.

In 2019, LifeHealthcare and CMR Surgical announced a collaboration to launch the Versius robotic keyhole surgery system in Australia and New Zealand.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU